0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurorehabilitation Therapy Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-3Y13752
Home | Market Reports | Health| Medical Facilities & Services
Global Neurorehabilitation Therapy Market Research Report 2023
BUY CHAPTERS

Global Neurorehabilitation Therapy Market Research Report 2025

Code: QYRE-Auto-3Y13752
Report
July 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neurorehabilitation Therapy Market Size

The global market for Neurorehabilitation Therapy was valued at US$ 1227 million in the year 2024 and is projected to reach a revised size of US$ 2142 million by 2031, growing at a CAGR of 8.4% during the forecast period.

Neurorehabilitation Therapy Market

Neurorehabilitation Therapy Market

Neurorehabilitation is a complex medical process which aims to aid recovery from a nervous system injury, and to minimize and/or compensate for any functional alterations resulting from it.
The neurorehabilitation therapy market is driven by a growing prevalence of neurological disorders and the increasing awareness of the importance of rehabilitation in improving the quality of life for affected individuals. Advances in medical technology and therapies, such as robotics, virtual reality, and neurostimulation, have expanded the possibilities for neurorehabilitation, fostering market growth. However, challenges in this market include the high cost of advanced rehabilitation technologies and therapies, limited accessibility to specialized rehabilitation centers in some regions, and the need for skilled healthcare professionals. Additionally, the effectiveness of neurorehabilitation can vary among individuals, making it essential to tailor therapies to each patient"s specific needs and conditions. Ongoing research and innovations in both treatment approaches and cost-effective solutions are crucial to addressing these challenges and further advancing the field of neurorehabilitation therapy.
This report aims to provide a comprehensive presentation of the global market for Neurorehabilitation Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurorehabilitation Therapy.
The Neurorehabilitation Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurorehabilitation Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurorehabilitation Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Neurorehabilitation Therapy Market Report

Report Metric Details
Report Name Neurorehabilitation Therapy Market
Accounted market size in year US$ 1227 million
Forecasted market size in 2031 US$ 2142 million
CAGR 8.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • General Hospital
  • Rehabilitation Specialist Hospital
  • Community Rehabilitation Center
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company VISHEE, Beijing Bo'ai Hospital, Beijing Rehabilitation Hospital of Capital Medical University, NCC, CHIEFTAIN, Tongji Hospital, Haobro Medical Device, DIH, Sun Java, Aoyang Health, PKUCare Rehabilitation Hospital, Beijing Puhua International Hospital, Xiangyu Medical, Beijing United Family Rehabilitation Hospital, Bionik Laboratories Corp, BioScience Managers Ltd, Bioventus, DIH (Hocoma AG), Ekso Bionics Holdings, Eodyne, Neofect, Neuro Rehab VR, Reha Technology AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Neurorehabilitation Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Neurorehabilitation Therapy Market growing?

Ans: The Neurorehabilitation Therapy Market witnessing a CAGR of 8.4% during the forecast period 2025-2031.

What is the Neurorehabilitation Therapy Market size in 2031?

Ans: The Neurorehabilitation Therapy Market size in 2031 will be US$ 2142 million.

Who are the main players in the Neurorehabilitation Therapy Market report?

Ans: The main players in the Neurorehabilitation Therapy Market are VISHEE, Beijing Bo'ai Hospital, Beijing Rehabilitation Hospital of Capital Medical University, NCC, CHIEFTAIN, Tongji Hospital, Haobro Medical Device, DIH, Sun Java, Aoyang Health, PKUCare Rehabilitation Hospital, Beijing Puhua International Hospital, Xiangyu Medical, Beijing United Family Rehabilitation Hospital, Bionik Laboratories Corp, BioScience Managers Ltd, Bioventus, DIH (Hocoma AG), Ekso Bionics Holdings, Eodyne, Neofect, Neuro Rehab VR, Reha Technology AG

What are the Application segmentation covered in the Neurorehabilitation Therapy Market report?

Ans: The Applications covered in the Neurorehabilitation Therapy Market report are General Hospital, Rehabilitation Specialist Hospital, Community Rehabilitation Center

What are the Type segmentation covered in the Neurorehabilitation Therapy Market report?

Ans: The Types covered in the Neurorehabilitation Therapy Market report are Brain Injury, Spinal Cord Injury, Peripheral Nerve Injury, Other

Recommended Reports

Neurorehabilitation Devices

Rehabilitation Equipment

Neuro Therapy Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurorehabilitation Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Brain Injury
1.2.3 Spinal Cord Injury
1.2.4 Peripheral Nerve Injury
1.2.5 Other
1.3 Market by Application
1.3.1 Global Neurorehabilitation Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 General Hospital
1.3.3 Rehabilitation Specialist Hospital
1.3.4 Community Rehabilitation Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurorehabilitation Therapy Market Perspective (2020-2031)
2.2 Global Neurorehabilitation Therapy Growth Trends by Region
2.2.1 Global Neurorehabilitation Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neurorehabilitation Therapy Historic Market Size by Region (2020-2025)
2.2.3 Neurorehabilitation Therapy Forecasted Market Size by Region (2026-2031)
2.3 Neurorehabilitation Therapy Market Dynamics
2.3.1 Neurorehabilitation Therapy Industry Trends
2.3.2 Neurorehabilitation Therapy Market Drivers
2.3.3 Neurorehabilitation Therapy Market Challenges
2.3.4 Neurorehabilitation Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurorehabilitation Therapy Players by Revenue
3.1.1 Global Top Neurorehabilitation Therapy Players by Revenue (2020-2025)
3.1.2 Global Neurorehabilitation Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Neurorehabilitation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neurorehabilitation Therapy Revenue
3.4 Global Neurorehabilitation Therapy Market Concentration Ratio
3.4.1 Global Neurorehabilitation Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurorehabilitation Therapy Revenue in 2024
3.5 Global Key Players of Neurorehabilitation Therapy Head office and Area Served
3.6 Global Key Players of Neurorehabilitation Therapy, Product and Application
3.7 Global Key Players of Neurorehabilitation Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurorehabilitation Therapy Breakdown Data by Type
4.1 Global Neurorehabilitation Therapy Historic Market Size by Type (2020-2025)
4.2 Global Neurorehabilitation Therapy Forecasted Market Size by Type (2026-2031)
5 Neurorehabilitation Therapy Breakdown Data by Application
5.1 Global Neurorehabilitation Therapy Historic Market Size by Application (2020-2025)
5.2 Global Neurorehabilitation Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neurorehabilitation Therapy Market Size (2020-2031)
6.2 North America Neurorehabilitation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neurorehabilitation Therapy Market Size by Country (2020-2025)
6.4 North America Neurorehabilitation Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neurorehabilitation Therapy Market Size (2020-2031)
7.2 Europe Neurorehabilitation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neurorehabilitation Therapy Market Size by Country (2020-2025)
7.4 Europe Neurorehabilitation Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurorehabilitation Therapy Market Size (2020-2031)
8.2 Asia-Pacific Neurorehabilitation Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neurorehabilitation Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Neurorehabilitation Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neurorehabilitation Therapy Market Size (2020-2031)
9.2 Latin America Neurorehabilitation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neurorehabilitation Therapy Market Size by Country (2020-2025)
9.4 Latin America Neurorehabilitation Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurorehabilitation Therapy Market Size (2020-2031)
10.2 Middle East & Africa Neurorehabilitation Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neurorehabilitation Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Neurorehabilitation Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 VISHEE
11.1.1 VISHEE Company Details
11.1.2 VISHEE Business Overview
11.1.3 VISHEE Neurorehabilitation Therapy Introduction
11.1.4 VISHEE Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.1.5 VISHEE Recent Development
11.2 Beijing Bo'ai Hospital
11.2.1 Beijing Bo'ai Hospital Company Details
11.2.2 Beijing Bo'ai Hospital Business Overview
11.2.3 Beijing Bo'ai Hospital Neurorehabilitation Therapy Introduction
11.2.4 Beijing Bo'ai Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.2.5 Beijing Bo'ai Hospital Recent Development
11.3 Beijing Rehabilitation Hospital of Capital Medical University
11.3.1 Beijing Rehabilitation Hospital of Capital Medical University Company Details
11.3.2 Beijing Rehabilitation Hospital of Capital Medical University Business Overview
11.3.3 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Introduction
11.3.4 Beijing Rehabilitation Hospital of Capital Medical University Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.3.5 Beijing Rehabilitation Hospital of Capital Medical University Recent Development
11.4 NCC
11.4.1 NCC Company Details
11.4.2 NCC Business Overview
11.4.3 NCC Neurorehabilitation Therapy Introduction
11.4.4 NCC Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.4.5 NCC Recent Development
11.5 CHIEFTAIN
11.5.1 CHIEFTAIN Company Details
11.5.2 CHIEFTAIN Business Overview
11.5.3 CHIEFTAIN Neurorehabilitation Therapy Introduction
11.5.4 CHIEFTAIN Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.5.5 CHIEFTAIN Recent Development
11.6 Tongji Hospital
11.6.1 Tongji Hospital Company Details
11.6.2 Tongji Hospital Business Overview
11.6.3 Tongji Hospital Neurorehabilitation Therapy Introduction
11.6.4 Tongji Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.6.5 Tongji Hospital Recent Development
11.7 Haobro Medical Device
11.7.1 Haobro Medical Device Company Details
11.7.2 Haobro Medical Device Business Overview
11.7.3 Haobro Medical Device Neurorehabilitation Therapy Introduction
11.7.4 Haobro Medical Device Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.7.5 Haobro Medical Device Recent Development
11.8 DIH
11.8.1 DIH Company Details
11.8.2 DIH Business Overview
11.8.3 DIH Neurorehabilitation Therapy Introduction
11.8.4 DIH Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.8.5 DIH Recent Development
11.9 Sun Java
11.9.1 Sun Java Company Details
11.9.2 Sun Java Business Overview
11.9.3 Sun Java Neurorehabilitation Therapy Introduction
11.9.4 Sun Java Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.9.5 Sun Java Recent Development
11.10 Aoyang Health
11.10.1 Aoyang Health Company Details
11.10.2 Aoyang Health Business Overview
11.10.3 Aoyang Health Neurorehabilitation Therapy Introduction
11.10.4 Aoyang Health Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.10.5 Aoyang Health Recent Development
11.11 PKUCare Rehabilitation Hospital
11.11.1 PKUCare Rehabilitation Hospital Company Details
11.11.2 PKUCare Rehabilitation Hospital Business Overview
11.11.3 PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Introduction
11.11.4 PKUCare Rehabilitation Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.11.5 PKUCare Rehabilitation Hospital Recent Development
11.12 Beijing Puhua International Hospital
11.12.1 Beijing Puhua International Hospital Company Details
11.12.2 Beijing Puhua International Hospital Business Overview
11.12.3 Beijing Puhua International Hospital Neurorehabilitation Therapy Introduction
11.12.4 Beijing Puhua International Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.12.5 Beijing Puhua International Hospital Recent Development
11.13 Xiangyu Medical
11.13.1 Xiangyu Medical Company Details
11.13.2 Xiangyu Medical Business Overview
11.13.3 Xiangyu Medical Neurorehabilitation Therapy Introduction
11.13.4 Xiangyu Medical Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.13.5 Xiangyu Medical Recent Development
11.14 Beijing United Family Rehabilitation Hospital
11.14.1 Beijing United Family Rehabilitation Hospital Company Details
11.14.2 Beijing United Family Rehabilitation Hospital Business Overview
11.14.3 Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Introduction
11.14.4 Beijing United Family Rehabilitation Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.14.5 Beijing United Family Rehabilitation Hospital Recent Development
11.15 Bionik Laboratories Corp
11.15.1 Bionik Laboratories Corp Company Details
11.15.2 Bionik Laboratories Corp Business Overview
11.15.3 Bionik Laboratories Corp Neurorehabilitation Therapy Introduction
11.15.4 Bionik Laboratories Corp Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.15.5 Bionik Laboratories Corp Recent Development
11.16 BioScience Managers Ltd
11.16.1 BioScience Managers Ltd Company Details
11.16.2 BioScience Managers Ltd Business Overview
11.16.3 BioScience Managers Ltd Neurorehabilitation Therapy Introduction
11.16.4 BioScience Managers Ltd Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.16.5 BioScience Managers Ltd Recent Development
11.17 Bioventus
11.17.1 Bioventus Company Details
11.17.2 Bioventus Business Overview
11.17.3 Bioventus Neurorehabilitation Therapy Introduction
11.17.4 Bioventus Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.17.5 Bioventus Recent Development
11.18 DIH (Hocoma AG)
11.18.1 DIH (Hocoma AG) Company Details
11.18.2 DIH (Hocoma AG) Business Overview
11.18.3 DIH (Hocoma AG) Neurorehabilitation Therapy Introduction
11.18.4 DIH (Hocoma AG) Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.18.5 DIH (Hocoma AG) Recent Development
11.19 Ekso Bionics Holdings
11.19.1 Ekso Bionics Holdings Company Details
11.19.2 Ekso Bionics Holdings Business Overview
11.19.3 Ekso Bionics Holdings Neurorehabilitation Therapy Introduction
11.19.4 Ekso Bionics Holdings Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.19.5 Ekso Bionics Holdings Recent Development
11.20 Eodyne
11.20.1 Eodyne Company Details
11.20.2 Eodyne Business Overview
11.20.3 Eodyne Neurorehabilitation Therapy Introduction
11.20.4 Eodyne Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.20.5 Eodyne Recent Development
11.21 Neofect
11.21.1 Neofect Company Details
11.21.2 Neofect Business Overview
11.21.3 Neofect Neurorehabilitation Therapy Introduction
11.21.4 Neofect Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.21.5 Neofect Recent Development
11.22 Neuro Rehab VR
11.22.1 Neuro Rehab VR Company Details
11.22.2 Neuro Rehab VR Business Overview
11.22.3 Neuro Rehab VR Neurorehabilitation Therapy Introduction
11.22.4 Neuro Rehab VR Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.22.5 Neuro Rehab VR Recent Development
11.23 Reha Technology AG
11.23.1 Reha Technology AG Company Details
11.23.2 Reha Technology AG Business Overview
11.23.3 Reha Technology AG Neurorehabilitation Therapy Introduction
11.23.4 Reha Technology AG Revenue in Neurorehabilitation Therapy Business (2020-2025)
11.23.5 Reha Technology AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Neurorehabilitation Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Brain Injury
 Table 3. Key Players of Spinal Cord Injury
 Table 4. Key Players of Peripheral Nerve Injury
 Table 5. Key Players of Other
 Table 6. Global Neurorehabilitation Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Neurorehabilitation Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Neurorehabilitation Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Neurorehabilitation Therapy Market Share by Region (2020-2025)
 Table 10. Global Neurorehabilitation Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Neurorehabilitation Therapy Market Share by Region (2026-2031)
 Table 12. Neurorehabilitation Therapy Market Trends
 Table 13. Neurorehabilitation Therapy Market Drivers
 Table 14. Neurorehabilitation Therapy Market Challenges
 Table 15. Neurorehabilitation Therapy Market Restraints
 Table 16. Global Neurorehabilitation Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Neurorehabilitation Therapy Market Share by Players (2020-2025)
 Table 18. Global Top Neurorehabilitation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurorehabilitation Therapy as of 2024)
 Table 19. Ranking of Global Top Neurorehabilitation Therapy Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Neurorehabilitation Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Neurorehabilitation Therapy, Headquarters and Area Served
 Table 22. Global Key Players of Neurorehabilitation Therapy, Product and Application
 Table 23. Global Key Players of Neurorehabilitation Therapy, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Neurorehabilitation Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Neurorehabilitation Therapy Revenue Market Share by Type (2020-2025)
 Table 27. Global Neurorehabilitation Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Neurorehabilitation Therapy Revenue Market Share by Type (2026-2031)
 Table 29. Global Neurorehabilitation Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Neurorehabilitation Therapy Revenue Market Share by Application (2020-2025)
 Table 31. Global Neurorehabilitation Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Neurorehabilitation Therapy Revenue Market Share by Application (2026-2031)
 Table 33. North America Neurorehabilitation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Neurorehabilitation Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Neurorehabilitation Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Neurorehabilitation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Neurorehabilitation Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Neurorehabilitation Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Neurorehabilitation Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Neurorehabilitation Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Neurorehabilitation Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Neurorehabilitation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Neurorehabilitation Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Neurorehabilitation Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Neurorehabilitation Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Neurorehabilitation Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Neurorehabilitation Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. VISHEE Company Details
 Table 49. VISHEE Business Overview
 Table 50. VISHEE Neurorehabilitation Therapy Product
 Table 51. VISHEE Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 52. VISHEE Recent Development
 Table 53. Beijing Bo'ai Hospital Company Details
 Table 54. Beijing Bo'ai Hospital Business Overview
 Table 55. Beijing Bo'ai Hospital Neurorehabilitation Therapy Product
 Table 56. Beijing Bo'ai Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 57. Beijing Bo'ai Hospital Recent Development
 Table 58. Beijing Rehabilitation Hospital of Capital Medical University Company Details
 Table 59. Beijing Rehabilitation Hospital of Capital Medical University Business Overview
 Table 60. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Therapy Product
 Table 61. Beijing Rehabilitation Hospital of Capital Medical University Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 62. Beijing Rehabilitation Hospital of Capital Medical University Recent Development
 Table 63. NCC Company Details
 Table 64. NCC Business Overview
 Table 65. NCC Neurorehabilitation Therapy Product
 Table 66. NCC Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 67. NCC Recent Development
 Table 68. CHIEFTAIN Company Details
 Table 69. CHIEFTAIN Business Overview
 Table 70. CHIEFTAIN Neurorehabilitation Therapy Product
 Table 71. CHIEFTAIN Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 72. CHIEFTAIN Recent Development
 Table 73. Tongji Hospital Company Details
 Table 74. Tongji Hospital Business Overview
 Table 75. Tongji Hospital Neurorehabilitation Therapy Product
 Table 76. Tongji Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 77. Tongji Hospital Recent Development
 Table 78. Haobro Medical Device Company Details
 Table 79. Haobro Medical Device Business Overview
 Table 80. Haobro Medical Device Neurorehabilitation Therapy Product
 Table 81. Haobro Medical Device Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 82. Haobro Medical Device Recent Development
 Table 83. DIH Company Details
 Table 84. DIH Business Overview
 Table 85. DIH Neurorehabilitation Therapy Product
 Table 86. DIH Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 87. DIH Recent Development
 Table 88. Sun Java Company Details
 Table 89. Sun Java Business Overview
 Table 90. Sun Java Neurorehabilitation Therapy Product
 Table 91. Sun Java Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 92. Sun Java Recent Development
 Table 93. Aoyang Health Company Details
 Table 94. Aoyang Health Business Overview
 Table 95. Aoyang Health Neurorehabilitation Therapy Product
 Table 96. Aoyang Health Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 97. Aoyang Health Recent Development
 Table 98. PKUCare Rehabilitation Hospital Company Details
 Table 99. PKUCare Rehabilitation Hospital Business Overview
 Table 100. PKUCare Rehabilitation Hospital Neurorehabilitation Therapy Product
 Table 101. PKUCare Rehabilitation Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 102. PKUCare Rehabilitation Hospital Recent Development
 Table 103. Beijing Puhua International Hospital Company Details
 Table 104. Beijing Puhua International Hospital Business Overview
 Table 105. Beijing Puhua International Hospital Neurorehabilitation Therapy Product
 Table 106. Beijing Puhua International Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 107. Beijing Puhua International Hospital Recent Development
 Table 108. Xiangyu Medical Company Details
 Table 109. Xiangyu Medical Business Overview
 Table 110. Xiangyu Medical Neurorehabilitation Therapy Product
 Table 111. Xiangyu Medical Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 112. Xiangyu Medical Recent Development
 Table 113. Beijing United Family Rehabilitation Hospital Company Details
 Table 114. Beijing United Family Rehabilitation Hospital Business Overview
 Table 115. Beijing United Family Rehabilitation Hospital Neurorehabilitation Therapy Product
 Table 116. Beijing United Family Rehabilitation Hospital Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 117. Beijing United Family Rehabilitation Hospital Recent Development
 Table 118. Bionik Laboratories Corp Company Details
 Table 119. Bionik Laboratories Corp Business Overview
 Table 120. Bionik Laboratories Corp Neurorehabilitation Therapy Product
 Table 121. Bionik Laboratories Corp Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 122. Bionik Laboratories Corp Recent Development
 Table 123. BioScience Managers Ltd Company Details
 Table 124. BioScience Managers Ltd Business Overview
 Table 125. BioScience Managers Ltd Neurorehabilitation Therapy Product
 Table 126. BioScience Managers Ltd Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 127. BioScience Managers Ltd Recent Development
 Table 128. Bioventus Company Details
 Table 129. Bioventus Business Overview
 Table 130. Bioventus Neurorehabilitation Therapy Product
 Table 131. Bioventus Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 132. Bioventus Recent Development
 Table 133. DIH (Hocoma AG) Company Details
 Table 134. DIH (Hocoma AG) Business Overview
 Table 135. DIH (Hocoma AG) Neurorehabilitation Therapy Product
 Table 136. DIH (Hocoma AG) Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 137. DIH (Hocoma AG) Recent Development
 Table 138. Ekso Bionics Holdings Company Details
 Table 139. Ekso Bionics Holdings Business Overview
 Table 140. Ekso Bionics Holdings Neurorehabilitation Therapy Product
 Table 141. Ekso Bionics Holdings Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 142. Ekso Bionics Holdings Recent Development
 Table 143. Eodyne Company Details
 Table 144. Eodyne Business Overview
 Table 145. Eodyne Neurorehabilitation Therapy Product
 Table 146. Eodyne Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 147. Eodyne Recent Development
 Table 148. Neofect Company Details
 Table 149. Neofect Business Overview
 Table 150. Neofect Neurorehabilitation Therapy Product
 Table 151. Neofect Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 152. Neofect Recent Development
 Table 153. Neuro Rehab VR Company Details
 Table 154. Neuro Rehab VR Business Overview
 Table 155. Neuro Rehab VR Neurorehabilitation Therapy Product
 Table 156. Neuro Rehab VR Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 157. Neuro Rehab VR Recent Development
 Table 158. Reha Technology AG Company Details
 Table 159. Reha Technology AG Business Overview
 Table 160. Reha Technology AG Neurorehabilitation Therapy Product
 Table 161. Reha Technology AG Revenue in Neurorehabilitation Therapy Business (2020-2025) & (US$ Million)
 Table 162. Reha Technology AG Recent Development
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Neurorehabilitation Therapy Picture
 Figure 2. Global Neurorehabilitation Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Neurorehabilitation Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Brain Injury Features
 Figure 5. Spinal Cord Injury Features
 Figure 6. Peripheral Nerve Injury Features
 Figure 7. Other Features
 Figure 8. Global Neurorehabilitation Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Neurorehabilitation Therapy Market Share by Application: 2024 VS 2031
 Figure 10. General Hospital Case Studies
 Figure 11. Rehabilitation Specialist Hospital Case Studies
 Figure 12. Community Rehabilitation Center Case Studies
 Figure 13. Neurorehabilitation Therapy Report Years Considered
 Figure 14. Global Neurorehabilitation Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Neurorehabilitation Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Neurorehabilitation Therapy Market Share by Region: 2024 VS 2031
 Figure 17. Global Neurorehabilitation Therapy Market Share by Players in 2024
 Figure 18. Global Top Neurorehabilitation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurorehabilitation Therapy as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Neurorehabilitation Therapy Revenue in 2024
 Figure 20. North America Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Neurorehabilitation Therapy Market Share by Country (2020-2031)
 Figure 22. United States Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Neurorehabilitation Therapy Market Share by Country (2020-2031)
 Figure 26. Germany Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Neurorehabilitation Therapy Market Share by Region (2020-2031)
 Figure 34. China Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Neurorehabilitation Therapy Market Share by Country (2020-2031)
 Figure 42. Mexico Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Neurorehabilitation Therapy Market Share by Country (2020-2031)
 Figure 46. Turkey Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Neurorehabilitation Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. VISHEE Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 50. Beijing Bo'ai Hospital Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 51. Beijing Rehabilitation Hospital of Capital Medical University Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 52. NCC Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 53. CHIEFTAIN Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 54. Tongji Hospital Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 55. Haobro Medical Device Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 56. DIH Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 57. Sun Java Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 58. Aoyang Health Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 59. PKUCare Rehabilitation Hospital Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 60. Beijing Puhua International Hospital Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 61. Xiangyu Medical Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 62. Beijing United Family Rehabilitation Hospital Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 63. Bionik Laboratories Corp Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 64. BioScience Managers Ltd Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 65. Bioventus Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 66. DIH (Hocoma AG) Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 67. Ekso Bionics Holdings Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 68. Eodyne Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 69. Neofect Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 70. Neuro Rehab VR Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 71. Reha Technology AG Revenue Growth Rate in Neurorehabilitation Therapy Business (2020-2025)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

RELATED REPORTS

Global Disposable Laparoscopic Dissector Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28P19620
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Neurosurgery Surgical Instruments Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14F16814
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Disposable Laparoscopic Grasping Forceps Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16C19880
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Activated Prothrombin Complex Concentrate (aPCC) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0O17020
Thu Sep 25 00:00:00 UTC 2025

Add to Cart